Table 2.
Differences Between Baseline and 12-month Outcome Scores Within BMA and Cortisone Injection Groups
| Baseline Score | 12-Month Score | P Value | |
|---|---|---|---|
| BMA (N = 13) | |||
| WOOS, mean (SD) | 1082.0 (192.8) | 684.0 (385.3) | 0.002∗ |
| QuickDASH, mean (SD) | 42.5 (10.1) | 25.5 (8.4) | <0.00∗ |
| QuickDASH Work, mean (SD) | 43.2 (23.6) | 18.1 (13.1) | 0.005∗ |
| QuickDASH Sport, mean (SD) | 61.4 (22.7) | 39.2 (25.3) | 0.003∗ |
| Pain VAS, mean (SD) | 4.3 (2.1) | 3.0 (2.8) | 0.13∗ |
| EQ5D-5L Mobility, median (IQR) | 1 (1-1) | 1 (1-1) | 1.00† |
| EQ5D-5L Selfcare, median (IQR) | 2 (1-3) | 2 (1-2) | 0.36† |
| EQ5D-5L Activities, median (IQR) | 2 (2-3) | 2 (2-2) | 0.16† |
| EQ5D-5L Pain, median (IQR) | 3 (3-4) | 2 (2-3) | 0.004† |
| EQ5D-5L Anxiety, median (IQR) | 1 (1-2) | 1 (1-2) | 0.25† |
| EQ5D-5L Health Score, median (IQR) | 75 (70-85) | 81 (75-85) | 0.27† |
| Cortisone (N = 12) | |||
| WOOS, mean (SD) | 1088.9 (262.8) | 1002.7 (429.2) | 0.54∗ |
| QuickDASH, mean (SD) | 39.4 (11.1) | 37.1 (18.7) | 0.59∗ |
| QuickDASH Work, mean (SD) | 32.0 (22.8) | 25.0 (16.5) | 0.47∗ |
| QuickDASH Sport, mean (SD) | 60.9 (11.9) | 49.2 (23.7) | 0.44∗ |
| Pain VAS, mean (SD) | 4.8 (1.8) | 5.1 (3.2) | 0.61∗ |
| EQ5D-5L Mobility, median (IQR) | 1 (1-1) | 1 (1-1) | 0.50† |
| EQ5D-5L Selfcare, median (IQR) | 2 (1.5-2) | 2 (1.5-3) | 1.00† |
| EQ5D-5L Activities, median (IQR) | 3 (2-3) | 3 (2-3) | 1.00† |
| EQ5D-5L Pain, median (IQR) | 3 (2-3.5) | 3 (2.5-3.5) | 0.75† |
| EQ5D-5L Anxiety, median (IQR) | 1 (1-2) | 1 (1-2.5) | 0.25† |
| EQ5D-5L Health Score, median (IQR) | 70 (70-75) | 67.5 (55-72.5) | 0.13† |
Bold values indicate statistical significance (P < 0.05).
IQR, interquartile range; n, number of participants; SD, standard deviation; VAS, Visual Analogue Scale; WOOS, Western Ontario Osteoarthritis of the Shoulder index.
∗
P value produced using 2-sided paired t test.
†
P value produced using 2-sided Wilcoxon signed rank test.